Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Theodore M. Brasky

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7781-609X; OpenAlex author ID A5000172773. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Use of Nonsteroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk in the Women's Health Initiative. Co-author DOI 10.1158/1055-9965.epi-24-0305↗
  2. Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic Cancer Risk: Findings from the Women's Health Initiative. Co-author DOI 10.1158/1055-9965.epi-20-1478↗
  3. Low-Dose Aspirin and Pancreatic Cancer Risk-Letter. Co-author DOI 10.1158/1055-9965.epi-17-0115↗
  4. Antioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) Study. Co-author DOI 10.1002/cncr.27936↗
  5. Types of fish consumed and fish preparation methods in relation to pancreatic cancer incidence: the VITAL Cohort Study. Co-author DOI 10.1093/aje/kws232↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juhua Luo · 1 shared paper, 2024 · strength 0.23
  2. Jean Wactawski‐Wende · 1 shared paper, 2017 · strength 0.15
  3. Thomas E. Rohan · 1 shared paper, 2021 · strength 0.11
  4. Fred K. Tabung · 1 shared paper, 2021 · strength 0.11
  5. Jin Qi · 1 shared paper, 2021 · strength 0.11
  6. Darwin Lewis Conwell · 1 shared paper, 2021 · strength 0.11
  7. Zobeida Cruz‐Monserrate · 1 shared paper, 2021 · strength 0.11
  8. Phil A. Hart · 1 shared paper, 2021 · strength 0.11
  9. Ka He · 2 shared papers, 2013 · strength 0.08
  10. Emily White · 2 shared papers, 2013 · strength 0.08
  11. Xuesong Han · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.